000			01905 a2200505 4500
005			20250517005334.0
264		0	_c20160211
008			201602s 0 0 eng d
022			_a1464-5491
024	7		_a10.1111/dme.12664 _2doi
040			_aNLM _beng _cNLM
100	1		_aColetta, D K
245	0	0	_aThe effect of muraglitazar on adiponectin signalling, mitochondrial function and fat oxidation genes in human skeletal muscle in vivo. _h[electronic resource]
260			_bDiabetic medicine : a journal of the British Diabetic Association _cMay 2015
300			_a657-64 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAMP-Activated Protein Kinases _xphysiology
650	0	4	_aAdiponectin _xblood
650	0	4	_aBiopsy
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aDiabetes Mellitus, Type 2 _xgenetics
650	0	4	_aFatty Acids, Nonesterified _xmetabolism
650	0	4	_aFemale
650	0	4	_aGlycine _xanalogs & derivatives
650	0	4	_aHumans
650	0	4	_aInsulin _xblood
650	0	4	_aInsulin Resistance _xphysiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitochondria, Muscle _xdrug effects
650	0	4	_aMuscle, Skeletal _xdrug effects
650	0	4	_aOxazoles _xpharmacology
650	0	4	_aOxidation-Reduction
650	0	4	_aPPAR alpha _xagonists
650	0	4	_aPPAR gamma _xagonists
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTriglycerides _xblood
700	1		_aFernandez, M
700	1		_aCersosimo, E
700	1		_aGastaldelli, A
700	1		_aMusi, N
700	1		_aDeFronzo, R A
773	0		_tDiabetic medicine : a journal of the British Diabetic Association _gvol. 32 _gno. 5 _gp. 657-64
856	4	0	_uhttps://doi.org/10.1111/dme.12664 _zAvailable from publisher's website
999			_c24437014 _d24437014